FDA advisers endorse prasugrel for approval

02/3/2009 | Google · NYTimes.com

A group of FDA advisers unanimously voted to recommend approval for prasugrel, an anti-clotting medicine from Eli Lilly and Co. and Daiichi Sankyo. The panel also said prasugrel's label should warn physicians against its use in people who have suffered a stroke or are possible candidates for open-heart surgery.

View Full Article in:

Google · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC